The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
Anidulafungin is a medicine being developed for treatment of patients with certain kinds of
fungal infections. These infections due to yeast (a type of fungus) in the mouth/esophagus,
in the blood or in other areas within the body.